Profile
SEEL VRTX REGN SGEN ARGX ALNY
Company Name Seelos Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $214.97K $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.01K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Dr. Raj Mehra J.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
SEEL VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 2 4 3 3 1
Quant Rating Sell Sell Buy Neutral Neutral Strong Sell
Trading
SEEL VRTX REGN SGEN ARGX ALNY
Last Close $0.37 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $3.9 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.19 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -90.51 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 94.74 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
SEEL VRTX REGN SGEN ARGX ALNY
1 Month Return 0 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return 0 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return -47.14 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return 44.53 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return 0 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return 31.11 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SEEL VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
SEEL VRTX REGN SGEN ARGX ALNY
Asset Growth -76.18 % -0.87 % -1.21 %
Gross Profit Growth -52567.92 % 10.25 % 22.93 %
Revenue Growth - 11.66 % 24.65 %
Revenue 3 Year - 45.6 % 91.56 %
Revenue 5 Year - 163.93 % 215.48 %
Revenue 10 Year -97.95 % 1632.15 % 494.04 %
EBIT Growth 42.89 % -93.69 % 10.13 %
Net Income Growth 50.25 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share 39.98 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share 91.41 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share 94.76 % 33.84 % -624.16 %
Operating Income Growth 42.89 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) 61.18 % -113.93 % 9.07 %
Operating 3 Year CFG 65.18 % -118.65 % -147.99 %
Operating 5 Year CFG 93.83 % -131.3 % -195.86 %
Operating 10 Year CFG 96.28 % 12.43 % -2622.09 %
EPS Growth 64.01 % -114.8 % 10.81 %
EPS Diluted Growth 64.01 % -114.97 % 10.81 %
Book Value Per Share -128.45 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -496.75 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share -127.31 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -107.15 % 1265.7 % 691.19 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -29.29 % 116.42 % -23.28 %
Free Cash Flow Growth 61.18 % -124.1 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2022
Profitability
SEEL VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 60.33 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM 171.82 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -13.07 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM 105.95 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 100 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM -13.72 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM -1480.04 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -130.69 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 10.71 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 0.05 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 4285.11 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 84.59 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -15.36 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -15.36 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 34.01 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM -659.09 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -130.69 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -0.02 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -0.02 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -0.02 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
SEEL VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $-0.03B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio -1267.1% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.04B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.04B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -7.73 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
SEEL VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.04B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $-0.03B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.01B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
SEEL VRTX REGN SGEN ARGX ALNY
Net Income $-0.04B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.16
ABCL AbCellera Biologics Inc. 2.01
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.49
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1
ABPWW 0.02
ABSI Absci Corporation 2.8
ABUS Arbutus Biopharma Corporation 3.3
ABVC ABVC BioPharma, Inc. 1.32
ABVX Abivax SA American Depositary Shares 6.85
ACAD ACADIA Pharmaceuticals Inc. 16.93
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4784
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.43
ACIU AC Immune SA 1.66
ACLX Arcellx, Inc. 56.26
ETFs With Exposure to SEEL
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 278.25
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.5
VXF Vanguard Extended Market Index Fund 0 177.37
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 94.59
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 94.58
VTSAX Vanguard Total Stock Market Index Fund 0 135.4
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VITSX Vanguard Total Stock Market Index Fund 0 135.42
IBRN iShares Neuroscience and Healthcare ETF 0.0146 21.49
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000308553 95.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
PSIL AdvisorShares Psychedelics ETF 0.16 11.36
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 254.04
Unlock